SCHEMBL16746575

SCHEMBL16746575

Cc1c(Cl)cc(C(F)(F)F)c2nc(CCc3cc(N4CCC(F)(F)C4)nn3C)nn12

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15549368 0.85 PDE10A (1.00) PDE10A
SCHEMBL15538187 0.77 PDE10A (1.00) PDE10A
SCHEMBL15537383 0.73 PDE10A (1.00) PDE10A
SCHEMBL15549793 0.72 PDE10A (1.00) PDE10A
SCHEMBL15537443 0.70 PDE10A (1.00) PDE10A
SCHEMBL15537442 0.70 PDE10A (1.00) PDE10A
SCHEMBL15538099 0.69 PDE10A (0.78) PDE10A
SCHEMBL15549617 0.69 PDE10A (1.00) PDE10A
SCHEMBL19560794 0.65 PDE10A (0.61) PDE10A
SCHEMBL19560852 0.65 PDE10A (0.52) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150148332-A1 TRIAZOLO COMPOUNDS AS PDE10 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2015-05-28 — — US disclosed
US-20150148332-A1 TRIAZOLO COMPOUNDS AS PDE10 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2015-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148332-A1 TRIAZOLO COMPOUNDS AS PDE10 INHIBITORS PDE3A, PDE3B, PDE5A PDE10A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback